AHIP goes after Big Pharma on drug prices in new ad campaign

AHIP launched a new advertising campaign blaming drug manufacturers for rising drug costs. 

The trade association is placing ads on broadcast, social media and in targeted Washington, D.C., publications, according to an April 24 news release. 

Robert Traynham, AHIPs executive vice president for public affairs and strategic initiatives, said the campaign "spotlights the critical role health insurance providers play in making health care more affordable and accessible for Americans every day." 

"Let's be clear, Big Pharma continues to deceive and divert attention from real solutions and the root cause of high drug prices — pharma's anti-competitive, price-gouging tactics," Mr. Traynham said. 

PhRMA, the trade association representing drug manufacturers, has pointed to insurers and pharmaceutical benefit managers as the reason for rising drug costs, Politico reported April 24. 

The advertising campaign comes as PBMs are facing increased scrutiny from lawmakers. In March, the House Committee on Oversight and Accountability opened an investigation into three PBMs for alleged anti-competitive practices. 

The ad campaign has a seven-figure price tag, Politico reported. 

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Top 40 articles from the past 6 months